The Mantoux test, also known as the tuberculin skin test, is a diagnostic tool used to detect latent or active tuberculosis infection. It involves injecting a small amount of purified protein derivative (PPD) under the skin of the forearm and observing the reaction after 48–72 hours. The test helps identify whether a person has been exposed to *Mycobacterium tuberculosis*, making it an important screening method for TB control and prevention programs worldwide.
A small amount of PPD is injected intradermally into the forearm. The injection site is then examined after 48–72 hours for swelling or induration.
A positive result indicates prior exposure to Mycobacterium tuberculosis. It does not confirm active disease but suggests latent infection or past contact with tuberculosis bacteria.
It is recommended for individuals at risk of tuberculosis, including healthcare workers, close contacts of TB patients, or those with weakened immune systems due to medical conditions.
Yes, false positives may occur in people vaccinated with BCG, and false negatives can appear in immunocompromised individuals, so results must be interpreted with clinical context.
No, it only indicates exposure or latent infection. Active tuberculosis requires further investigations like chest X‑ray, sputum tests, or molecular diagnostics for confirmation.
BCG vaccination, immunosuppression, malnutrition, or recent TB infection can influence results, leading to false positives or false negatives that require careful interpretation.
A negative result usually means no TB exposure. However, in immunocompromised individuals, false negatives are possible, so further evaluation may still be necessary.
...
Didn't recieved OTP Yet? Resend OTP